Abstract: A UE can enable a VoWIFI service, receive hidden SSID information, and register with a core network via a RAN. The UE can monitor a first signal strength of a first signal from the RAN. The UE can scan for a second signal from a WLAN, and when found, can measure a second signal strength of the second signal. The UE can determine whether the first signal strength is at or below a first threshold. If so, and if the WLAN is untrusted, the UE can probe it with the hidden SSID information. If the untrusted WLAN responds, the UE can send an access request to an untrusted WLAN access point. The UE can receive, via the untrusted WLAN access point, an authentication challenge from an ePDG. If the UE passes the authentication challenge, the UE can register with the core network via the untrusted WLAN and the ePDG.

Abstract: Tie fastening devices, systems apparatus, and methods of fastening and staking concrete cloth, and landscape and erosion control stabilizer sheets and timbers in place with a drill adapted fastener. The fasteners can elongated with anvil top ends that can be mounted to a drill chuck and lower cutting heads with arrow shaped blades that can raised burr edges for driving into ground surfaces.

Abstract: The present invention relates to a process for producing N-{(1S)-1-[2-(1-{[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl]carbonyl}piperidin-4-yl)-5-chlorophenyl]ethyl}acetamide, and novel crystalline salts, hydrates, solvates, and polymorphic forms thereof.

Abstract: The present invention relates to a process for producing N-{(1S)-1-[2-(1-{[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl]carbonyl}piperidin-4-yl)-5-chlorophenyl]ethyl}acetamide, and novel crystalline salts, hydrates, solvates, and polymorphic forms thereof.

Abstract: This invention includes methods of fabricating brachytherapy implant seeds, methods of fabricating brachytherapy implant seed cores, and brachytherapy implant seeds independent of method of fabrication. In one implementation, a brachytherapy implant seed includes a sealed inorganic metallic cylinder having a radioactive core received therein. The radioactive core includes an inorganic amorphous silicate glass tube having an exterior surface extending axially along the tube. An inorganic crystalline ceramic coating is received on at least a portion of the inorganic amorphous glass tube exterior surface. The coating includes a therapeutic dose of radioactive material. A radiographic marker is received within the sealed inorganic metallic cylinder. Other aspects and implementations are contemplated.

Abstract: This invention relates to a 50% drug loaded compressed tablet formulation for efavirenz. Efavirenz is a non-nucleoside reverse trancriptase inhibitor being studied clinically for use in the treatment of HIV infections and AIDS.

Abstract: The present invention is related to a powder, powder blend or granulation formulation of 3-[5-(4-methanesulfonyl-piperazin-1-ylmethyl)-1H-indol-2-yl]-1H-quinolin-2-one, a tyrosine kinase inhibitor, which is adapted for reconstitution with a diluent. This invention is also related to a prepared aqueous suspension, or dispersion, formulation, particularly to a stable oral pharmaceutical formulation, comprising granules of 3-[5-(4-methanesulfonyl-piperazin-1-ylmethyl)-1H-indol-2-yl]-1H-quinolin-2-one mixed with a diluent. Additionally, the present invention is related to the method of preparing these formulations.

Abstract: This invention includes methods of fabricating brachytherapy implant seeds, methods of fabricating brachytherapy implant seed cores, and brachytherapy implant seeds independent of method of fabrication. In one implementation, a brachytherapy implant seed includes a sealed inorganic metallic cylinder having a radioactive core received therein. The radioactive core includes an inorganic amorphous silicate glass tube having an exterior surface extending axially along the tube. An inorganic crystalline ceramic coating is received on at least a portion of the inorganic amorphous glass tube exterior surface. The coating includes a therapeutic dose of radioactive material. A radiographic marker is received within the sealed inorganic metallic cylinder. Other aspects and implementations are contemplated.

Abstract: A composite structure (1) includes a solid carrier (2), which is at least partially covered by a first adhesive layer (3). This first adhesive layer (3) is strengthened by strengthening material (4) arranged on said first adhesive layer (3). The invention further relates to a method of making such a composite structure. This composite structure may be in the form of a bowl-shaped structure to receive a bowl-shaped cooking pan in a heating device.